Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
复制标题
DOI:
10.1016/j.cgh.2014.05.011
复制
发表时间:
2015-10
影响因子:
12.6
通讯作者:
Wade, James B.
中科院分区:
文献类型:
--
作者:
Bajaj, Jasmohan S.;Heuman, Douglas M.;Sterling, Richard K.;Sanyal, Arun J.;Siddiqui, Muhammad;Matherly, Scott;Luketic, Velimir;Stravitz, R. Todd;Fuchs, Michael;Thacker, Leroy R.;Gilles, HoChong;White, Melanie B.;Unser, Ariel;Hovermale, James;Gavis, Edith;Noble, Nicole A.;Wade, James B.
Detection of covert hepatic encephalopathy (CHE) is difficult but point of care testing could increase rates of diagnosis. We aimed to validate the ability of the smartphone app EncephalApp, a streamlined version of Stroop App, to detect CHE. We evaluated face validity, test–retest reliability, and external validity. Patients with cirrhosis (n=167; 38% with overt HE [OHE]; mean age, 55 years; mean model for end-stage liver disease score, 12) and controls (n=114) were each given a paper and pencil cognitive battery (standard) along with EncephalApp. EncephalApp has Off and On states; results measured were: OffTime, OnTime, OffTime+OnTime, and number of runs required to complete 5 off and on runs. Thirty-six patients with cirrhosis underwent driving simulation tests, and EncephalApp results were correlated with results. Test–retest reliability was analyzed in a subgroup of patients. The test was performed before and after transjugular intra-hepatic portosystemic shunt placement, before and after correction for hyponatremia, to determine external validity. All patients with cirrhosis performed worse on paper and pencil and EncephalApp tests than controls. Patients with cirrhosis and OHE performed worse than those without OHE. Age-dependent EncephalApp cut-offs (younger or older than 45 years) were set. An OffTime+OnTime value of >190 seconds identified all patients with CHE with an area under the receiver operator characteristic (AUROC) value of 0.91; the AUROC value was 0.88 for diagnosis of CHE in those without OHE. EncephalApp times correlated with crashes and illegal turns in driving simulation tests. Test–retest reliability was high (intra-class coefficient, 0.83) among 30 patients retested 1–3 months apart. OffTime+OnTime increased significantly (206 vs 255, P=.007) among 10 patients retested 33±7 days after transjugular intra-hepatic portosystemic shunt placement. OffTime+OnTime decreased significantly (242 vs 225, P=.03) in 7 patients tested before and after correction for hyponatremia (126±3 to 132±4 meq/L, P=.01), 10±5 days apart. A smartphone app called EncephalApp has good face validity, test–retest reliability, and external validity for the diagnosis of CHE.
登录
查看更多内容
影响因子:
29.4
作者:
Bajaj JS;Schubert CM;Heuman DM;Wade JB;Gibson DP;Topaz A;Saeian K;Hafeezullah M;Bell DE;Sterling RK;Stravitz RT;Luketic V;White MB;Sanyal AJ
通讯作者:
Sanyal AJ
影响因子:
29.4
作者:
Kircheis, Gerald;Knoche, Anja;Haeussinger, Dieter
通讯作者:
Haeussinger, Dieter
影响因子:
1.3
作者:
Zhang, Long Jiang;Yang, Guifen;Qi, Ji
通讯作者:
Qi, Ji
影响因子:
13.5
作者:
Prasad, Srinivasa;Dhiman, Radha K.;Agarwal, Ritesh
通讯作者:
Agarwal, Ritesh
影响因子:
25.7
作者:
Ahluwalia, Vishwadeep;Wade, James B.;Bajaj, Jasmohan S.
通讯作者:
Bajaj, Jasmohan S.